Associations of the IL-1B level, IL-1A and IL-1B gene polymorphisms and ankylosing spondylitis risk in a Chinese Han population
- PMID: 31726259
- DOI: 10.1016/j.cyto.2019.154918
Associations of the IL-1B level, IL-1A and IL-1B gene polymorphisms and ankylosing spondylitis risk in a Chinese Han population
Abstract
Introduction: The aim of this study was to investigate the effect of interleukin (IL)-1A and IL-1B gene polymorphisms on ankylosing spondylitis (AS) susceptibility in a Chinese population. Additionally, we examined the association of IL-1B level with different genotype of rs2853550 polymorphism and clinicopathological features of AS patients.
Materials and methods: The IL-1B concentration in plasma was determined by an enzyme-linked immunosorbent assay. The IL-1A rs3783546, IL-1A rs3783550 and IL-1B rs2853550 gene polymorphisms were determined by using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Results: Our data indicated that the average plasma IL-1B concentration in the AS patients was markedly higher than in the control samples. Subgroup analyses suggested that there was no significant association between plasma IL-1B concentration and sex, age, HLA-B27, C-reactive protein (CRP), or grade of the sacroiliac joint in AS patients. We also found that the IL-1B rs2853550 AG genotype showed significantly correlation with an increased risk of AS. In comparing AS patients to control participants, elevated plasma concentrations were observed in AS patients while significant differences were found between the IL-1B rs2853550 AA genotypes. There is a negative correlation between the IL-1A rs3783550 and IL-1A rs3783546 polymorphisms in the AS patients in relation to controls.
Conclusions: The IL-1B concentration in plasma was markedly higher in cases and AA genotype carriers. Furthermore, IL-1B rs2853550 AG was a genetic contributor to AS risk in a Chinese population.
Keywords: Ankylosing spondylitis; IL-1A; IL-1B; Polymorphism.
Copyright © 2019 Elsevier Ltd. All rights reserved.
Similar articles
-
Association of IL-1A and IL-1B polymorphisms with ankylosing spondylitis among the Chinese Han population: a case-control study.Oncotarget. 2017 Apr 25;8(17):28278-28284. doi: 10.18632/oncotarget.16004. Oncotarget. 2017. PMID: 28423679 Free PMC article.
-
IL-1B rs2853550 polymorphism contributes to esophageal cancer susceptibility in Chinese Han population of Northwest China.Mol Med. 2020 Jun 11;26(1):57. doi: 10.1186/s10020-020-00178-y. Mol Med. 2020. PMID: 32527212 Free PMC article.
-
Associations of the VEGF level, VEGF rs2010963 G/C gene polymorphism and ankylosing spondylitis risk in a Chinese Han population.Immunol Lett. 2016 Nov;179:56-60. doi: 10.1016/j.imlet.2016.09.003. Epub 2016 Sep 13. Immunol Lett. 2016. PMID: 27637764
-
Genetic polymorphism of interleukin-1A (IL-1A), IL-1B, and IL-1 receptor antagonist (IL-1RN) and prostate cancer risk.Asian Pac J Cancer Prev. 2014;15(20):8741-7. doi: 10.7314/apjcp.2014.15.20.8741. Asian Pac J Cancer Prev. 2014. PMID: 25374200 Review.
-
The contribution of genes outside the major histocompatibility complex to susceptibility to ankylosing spondylitis.Curr Opin Rheumatol. 2008 Jul;20(4):384-91. doi: 10.1097/BOR.0b013e32830460fe. Curr Opin Rheumatol. 2008. PMID: 18525349 Review.
Cited by
-
Exploring causal correlations between inflammatory cytokines and ankylosing spondylitis: a bidirectional mendelian-randomization study.Front Immunol. 2023 Nov 20;14:1285106. doi: 10.3389/fimmu.2023.1285106. eCollection 2023. Front Immunol. 2023. PMID: 38054001 Free PMC article.
-
The causal relationship between immune cells and ankylosing spondylitis: a bidirectional Mendelian randomization study.Arthritis Res Ther. 2024 Jan 16;26(1):24. doi: 10.1186/s13075-024-03266-0. Arthritis Res Ther. 2024. PMID: 38229175 Free PMC article.
-
Polymorphism of IL-1β rs16944(T/C) Associated with Serum Levels of IL-1β and Subsequent Stimulation of Extracellular Matrix Degradation Affects Intervertebral Disk Degeneration Susceptibility.Ther Clin Risk Manag. 2021 May 24;17:453-461. doi: 10.2147/TCRM.S308653. eCollection 2021. Ther Clin Risk Manag. 2021. PMID: 34079267 Free PMC article.
-
Eucommia ulmoides Oliver's Multitarget Mechanism for Treatment of Ankylosing Spondylitis: A Study Based on Network Pharmacology and Molecular Docking.Evid Based Complement Alternat Med. 2022 Oct 11;2022:3699146. doi: 10.1155/2022/3699146. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 36267087 Free PMC article.
-
Colon mucosal proteomics of ankylosing spondylitis versus gut inflammation.PLoS One. 2024 Dec 13;19(12):e0315324. doi: 10.1371/journal.pone.0315324. eCollection 2024. PLoS One. 2024. PMID: 39671362 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous